Oncolytic Virus Market Worth USD 24.31 Billion by end of 2026

The global Oncolytic Virus market size was valued at USD 15.51 million in 2019 and will reach 24.31 million by the end of 2026, growing at a CAGR of 6.81% during 2020-2026.

Get Detailed Analysis of COVID-19 Impact on Oncolytic Virus Market @ https://reports.valuates.com/request/sample/QYRE-Othe-4D244/oncolytic_virus_market

This report focuses on Oncolytic Virus volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Oncolytic Virus market size by analyzing historical data and future prospect.

View Full Report: https://reports.valuates.com/market-reports/QYRE-Othe-4D244/oncolytic-virus

Regionally, this report categorizes the sales of Oncolytic Virus in North America, Europe, China, Australia, etc.

For the manufacturers covered, this report analyses the Oncolytic Virus manufacturing sites, sales, ex-factory price, revenue and market share for each company.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt and will significantly affect the Oncolytic Virus market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Oncolytic Virus industry.


BY COMPANY

o Amgen
o Shanghai Sunway Biotech
o Oncolytics Biotech
o Viralytics
o Transgene SA
o Oncolys BioPharma
o Targovax
o PsiOxus Therapeutics
o SillaJen Biotherapeutics
o Sorrento Therapeutics
o Lokon Pharma
o Genelux Corporation
o Vyriad
o TILT Biotherapeutics
o Cold Genesys


SEGMENT BY TYPE

o Imlygic
o Oncorine
o Others

SEGMENT BY APPLICATION

o Melanoma
o Other Cancers

BY REGION

o North America
o Europe
o China
o Australia
o RoW

Valuates Reports
sales@valuates.com
For U.S. Toll Free Call +1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp : +91-9945648335

Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
Linkedin - https://in.linkedin.com/company/valuatesreports
Facebook - https://www.facebook.com/valuatesreports/

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

Valuates is curating premium Market Research Reports from the leading publishers around the globe. We will help you map your information needs to our report repository of Market research reports and guide you through your purchasing decision. We are based out of Silicon Valley of India (Bengaluru) and provide 24/6 online and offline support to all our customers and just a phone call away.

This release was published on openPR.